EFFICACY OF SUBCUTANEOUS HOMOHARRINGTONINE IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT TO TYROSINE KINASE INHIBITORS (TKI) AND HARBORING A BCR-ABL MUTATION

被引：0
|
作者：
Marin, D. [1 ]
Maloisel, F. [3 ]
Legros, L. [2 ]
Nicolini, F. E. [4 ]
Roy, L. [5 ]
Rousselot, P. [6 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] CHU Hop Archet, Nice, France
[3] CHU Hosp Civil, Strasbourg, France
[4] CHU Hop Edouard Herriot, Lyon, France
[5] CHU Hop Jean Bernard, Poitiers, France
[6] Hop Andre Mignot, Le Chesnay, France
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O139
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Tgrx-678, a Potent BCR-ABL Allosteric Inhibitor in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant/Refractory Chronic Myeloid Leukemia (CML): Preliminary Results of Phase I Study
    Jiang, Qian
    Zhang, Yanli
    Wang, Qiang
    Weng, Jianyu
    Liu, Zhenfang
    Chen, Suning
    Weiming, Li
    Liu, Bingcheng
    Liu, Zhuogang
    Wang, Yihan
    Cao, Jingrong
    BLOOD, 2023, 142
  • [32] New BCR-ABL inhibitors in chronic myeloid leukemia
    Rea, Delphine
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Detection of BCR-ABL point mutations in patients with chronic myeloid leukemia (CML) resistant to imatinib.
    Silveira, Rosana A.
    Albuquerque, Dulcineia M.
    Assis, Angela M.
    Ichihara, Edson
    de Souza, Carmino A.
    Costa, Fernando F.
    Delamain, Marcia T.
    Vigorito, Afonso C.
    Lorand-Metze, Irene
    Miranda, Eliana
    Pagnano, Katia B. B.
    BLOOD, 2006, 108 (11) : 289B - 289B
  • [34] ANALYSIS OF THE REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT WITH INHIBITORS OF THE TYROSINE KINASE BCR-ABL
    Sanz Ruperez, A.
    Ruiz Gomez, F.
    Garcia Gutierrez, V
    Herrera Puente, P.
    Calbacho Robles, M.
    Velazquez Kennedy, K.
    Geijo Roman, Martinez C.
    Lopez Jimenez, J.
    HAEMATOLOGICA, 2017, 102 : 279 - 279
  • [35] Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)
    Montoriol-Sabate, Carme
    Martinez-Laperche, Carolina
    Jimenez-Gamiz, P.
    Collado, Rosa
    Minguela-Puras, Alfredo
    Pinan-Frances, M. A.
    Bellosillo, B.
    Martinez-Lopez, Joaquin
    Gonzalez, Marcos
    Larrayoz, Maria Jose
    Calasanz, MaJose
    Gomez-Casares, Maria Teresa
    Gonzalez-Brito, G.
    Soler, Gloria
    Roman, Jose
    Jimenez-Velasco, A.
    Buno, Ismael
    BLOOD, 2013, 122 (21)
  • [36] BGB324 Inhibits BCR-ABL TKI-Resistant Chronic Myeloid Leukemia
    Ben Batalla, Isabel
    Erdmann, Robert
    Jorgensen, Heather
    Mitchell, Rebecca
    Ernst, Thomas
    von Amsberg, Gunhild
    Schafhausen, Philippe
    Rankin, Stephen
    Clark, Richard E.
    Koschmieder, Steffen
    Schultze, Alexander
    Mitra, Subir
    Vandenberghe, Peter
    Bruemmendorf, Tim H.
    Carmeliet, Peter
    Helgason, Gudmundur
    Hochhaus, Andreas
    Pantel, Klaus
    Bokemeyer, Carsten
    Holyoake, Tessa L.
    Loges, Sonja
    BLOOD, 2015, 126 (23)
  • [37] Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemia
    Verma, Dushyant
    Fava, Carmen
    Kantarjian, Hagop
    Cortes, Jorge
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (04) : 256 - 257
  • [38] Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
    Jabbour, Elias
    Kantarjian, Hagop M.
    Jones, Dan
    Reddy, Neeli
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Burger, Jan
    Cortes, Jorge
    BLOOD, 2008, 112 (13) : 4839 - 4842
  • [39] BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naive and -exposed Southeast Asian chronic myeloid leukemia patients
    Wongboonma, Wanwisa
    Thongnoppakhun, Wanna
    Auewarakul, Chirayu U.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 92 (02) : 259 - 265
  • [40] SCREENING OF EXON 6 BCR-ABL KINASE DOMAIN MUTATIONS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH KINASE INHIBITORS USING DHPLC
    De Souza, C. A.
    Mascarenhas, C.
    Cunha, A.
    Pagnano, K.
    Silveira, R.
    Costa, F.
    Pasquini, R.
    Clementino, N.
    De Souza, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 540 - 540
12345